Report Detail
Global Prostate Cancer Treatment Drugs Market Size, Status and Forecast 2019-2025
- RnM3398467 |
- 28 June, 2019 |
- Global |
- 93 Pages |
- QYResearch |
- Other
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players are investing in research for the development of therapeutic products for the treatment of such tumors. For instance, there is a strong pipeline of products such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in their phase 3 studies and are projected to enter the market in the near future. In addition, many generic products are likely to enter the market owing to the expiry of patents of the major existing products during the forecast period. Thus, these factors are expected to drive growth.
Asia Pacific is anticipated to be the fastest growing market over the forecast period. Rising awareness of such tumors would primarily drive growth. Governments of various countries in this region are playing a vital role in creating awareness through programs and online portals that provide detailed information regarding screening & diagnosis through PSA blood tests and DRE for male patients over 50 years of age.
In 2018, the global Prostate Cancer Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Prostate Cancer Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prostate Cancer Treatment Drugs development in United States, Europe and China.
The key players covered in this study
Johnson & Johnson
Astella
Sanofi
Ipsen
Bayer
AstraZeneca
Dendreon
...
Market segment by Type, the product can be split into
Zytiga
Gonax
Lupron
Zoladex
Decapeptyl
Eligard
Vantas
Casodex
Others
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Prostate Cancer Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Prostate Cancer Treatment Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Prostate Cancer Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Zytiga
- 1.4.3 Gonax
- 1.4.4 Lupron
- 1.4.5 Zoladex
- 1.4.6 Decapeptyl
- 1.4.7 Eligard
- 1.4.8 Vantas
- 1.4.9 Casodex
- 1.4.10 Others
- 1.5 Market by Application
- 1.5.1 Global Prostate Cancer Treatment Drugs Market Share by Application (2014-2025)
- 1.5.2 Hospitals
- 1.5.3 Ambulatory Surgical Centers
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Prostate Cancer Treatment Drugs Market Size
- 2.2 Prostate Cancer Treatment Drugs Growth Trends by Regions
- 2.2.1 Prostate Cancer Treatment Drugs Market Size by Regions (2014-2025)
- 2.2.2 Prostate Cancer Treatment Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Prostate Cancer Treatment Drugs Market Size by Manufacturers
- 3.1.1 Global Prostate Cancer Treatment Drugs Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Prostate Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Prostate Cancer Treatment Drugs Key Players Head office and Area Served
- 3.3 Key Players Prostate Cancer Treatment Drugs Product/Solution/Service
- 3.4 Date of Enter into Prostate Cancer Treatment Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Prostate Cancer Treatment Drugs Market Size by Type (2014-2019)
- 4.2 Global Prostate Cancer Treatment Drugs Market Size by Application (2014-2019)
5 United States
- 5.1 United States Prostate Cancer Treatment Drugs Market Size (2014-2019)
- 5.2 Prostate Cancer Treatment Drugs Key Players in United States
- 5.3 United States Prostate Cancer Treatment Drugs Market Size by Type
- 5.4 United States Prostate Cancer Treatment Drugs Market Size by Application
6 Europe
- 6.1 Europe Prostate Cancer Treatment Drugs Market Size (2014-2019)
- 6.2 Prostate Cancer Treatment Drugs Key Players in Europe
- 6.3 Europe Prostate Cancer Treatment Drugs Market Size by Type
- 6.4 Europe Prostate Cancer Treatment Drugs Market Size by Application
7 China
- 7.1 China Prostate Cancer Treatment Drugs Market Size (2014-2019)
- 7.2 Prostate Cancer Treatment Drugs Key Players in China
- 7.3 China Prostate Cancer Treatment Drugs Market Size by Type
- 7.4 China Prostate Cancer Treatment Drugs Market Size by Application
8 Japan
- 8.1 Japan Prostate Cancer Treatment Drugs Market Size (2014-2019)
- 8.2 Prostate Cancer Treatment Drugs Key Players in Japan
- 8.3 Japan Prostate Cancer Treatment Drugs Market Size by Type
- 8.4 Japan Prostate Cancer Treatment Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Prostate Cancer Treatment Drugs Market Size (2014-2019)
- 9.2 Prostate Cancer Treatment Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Prostate Cancer Treatment Drugs Market Size by Type
- 9.4 Southeast Asia Prostate Cancer Treatment Drugs Market Size by Application
10 India
- 10.1 India Prostate Cancer Treatment Drugs Market Size (2014-2019)
- 10.2 Prostate Cancer Treatment Drugs Key Players in India
- 10.3 India Prostate Cancer Treatment Drugs Market Size by Type
- 10.4 India Prostate Cancer Treatment Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Prostate Cancer Treatment Drugs Market Size (2014-2019)
- 11.2 Prostate Cancer Treatment Drugs Key Players in Central & South America
- 11.3 Central & South America Prostate Cancer Treatment Drugs Market Size by Type
- 11.4 Central & South America Prostate Cancer Treatment Drugs Market Size by Application
12 International Players Profiles
- 12.1 Johnson & Johnson
- 12.1.1 Johnson & Johnson Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Prostate Cancer Treatment Drugs Introduction
- 12.1.4 Johnson & Johnson Revenue in Prostate Cancer Treatment Drugs Business (2014-2019)
- 12.1.5 Johnson & Johnson Recent Development
- 12.2 Astella
- 12.2.1 Astella Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Prostate Cancer Treatment Drugs Introduction
- 12.2.4 Astella Revenue in Prostate Cancer Treatment Drugs Business (2014-2019)
- 12.2.5 Astella Recent Development
- 12.3 Sanofi
- 12.3.1 Sanofi Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Prostate Cancer Treatment Drugs Introduction
- 12.3.4 Sanofi Revenue in Prostate Cancer Treatment Drugs Business (2014-2019)
- 12.3.5 Sanofi Recent Development
- 12.4 Ipsen
- 12.4.1 Ipsen Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Prostate Cancer Treatment Drugs Introduction
- 12.4.4 Ipsen Revenue in Prostate Cancer Treatment Drugs Business (2014-2019)
- 12.4.5 Ipsen Recent Development
- 12.5 Bayer
- 12.5.1 Bayer Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Prostate Cancer Treatment Drugs Introduction
- 12.5.4 Bayer Revenue in Prostate Cancer Treatment Drugs Business (2014-2019)
- 12.5.5 Bayer Recent Development
- 12.6 AstraZeneca
- 12.6.1 AstraZeneca Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Prostate Cancer Treatment Drugs Introduction
- 12.6.4 AstraZeneca Revenue in Prostate Cancer Treatment Drugs Business (2014-2019)
- 12.6.5 AstraZeneca Recent Development
- 12.7 Dendreon
- 12.7.1 Dendreon Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Prostate Cancer Treatment Drugs Introduction
- 12.7.4 Dendreon Revenue in Prostate Cancer Treatment Drugs Business (2014-2019)
- 12.7.5 Dendreon Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Prostate Cancer Treatment Drugs . Industry analysis & Market Report on Prostate Cancer Treatment Drugs is a syndicated market report, published as Global Prostate Cancer Treatment Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Prostate Cancer Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
